Summary Aluminium phthalocyanines substituted to different degrees with hydrophilic sulphonic acid and hydrophobic phthalimidomethyl groups were investigated in vivo as new agents for the photodynamic therapy of malignant tumours. Parameters studied included the photodynamic action on EMT-6 mammary tumours in BALB/c mice, the therapeutic window and the potential for direct cell killing, assayed via an in vivo/in vitro test. Although the efficiency of photoinactivation of the EMT-6 tumour increases by a factor of ten with reduction of the number of sulphonic acid groups from four to two, no further effect was seen with the addition of the hydrophobic phthalimidomethyl groups. Addition of the latter groups however increased the potential for direct cell killing by a factor of two and expanded the therapeutic window by a factor of four, thus improving the usefulness of the dye as a photosensitiser for the photodynamic therapy of cancer.
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Photodynamic therapy of cancer is a treatment which exploits the ability of certain dyes to absorb light and, via an excited state, interact with and cause damage to substrate molecules. If the dye, through differential rates of uptake or release by neoplastic tissue, as compared to normal tissue, concentrates in the tumour, activation with light of appropriate wavelengths can induce selective destruction of the malignant tumour (Kessel, 1984; Moan, 1986; Dougherty, 1987) . Porphyrin based photosensitisers and in particular Photofrin IItm (P-IT), a commercially available preparation of haematoporphyrin derivatives, have been extensively investigated; however, although these compounds absorb visible light efficiently at short wavelengths (E4NZ 105 M-cm 1), they have much less intense absorbance maxima at useful therapeutic wavelengths (6630103M-' cm '). Phthalocyanines (Pc) have been proposed as sensitisers to supersede P-II (for reviews see van Lier & Spikes, 1989; van Lier, 1990; Rosenthal, 1991) . This is due to the high molar absorptivity of these compounds at wavelengths permitting greater penetration of light in normal tissues (typically e 105M -cm-I at 670-680 nm when fully monomerised). Due to the extreme insolubility of unsubstituted Pc in most common solvents, attention has focused mainly on sulphonated derivatives, which are water soluble.
A correlation has been found to exist between hydrophobicity of the sulphonated Pc and photodynamic potency (Brasseur et al., 1978a) , the activity increasing as the number of sulphonic acid groups is decreased from four to two. It has been postulated that this relationship is due to the increasing amphiphilic nature of the lower sulphonates, which leads to greater membrane penetration. We recently tested this hypothesis, in vitro, using sulphonated phthalimidomethyl aluminium phthalocyanine (AlPcSP) (Figure 1 ), a novel photosensitiser substituted with both hydrophilic and hydrophobic groups (Paquette et al., 1991a) . It was found that the lower sulphonated fractions, with added phthalimidomethyl groups, were more effective with regard to photodynamic inactivation of V-79 Chinese hamster fibroblasts, compared to the corresponding sulphonates without phthalimidomethyl substituents. This enhanced photoactivity was directly related to cell uptake of these dyes and correlated to an increase in the hydrophobic character due to the addition of the phthalimidomethyl groups.
We now present in vivo photodynamic tumour response results, and evaluate the potential for direct tumour cell killing for these substituted sulphonated phthalocyanines. In addition, it has been reported that PDT can result in vascular stasis and traumatic shock reactions (Ferrario & Gomer, 1990) , mediated by release of eicosanoids from endothelial cells (Fingar et al., 1991) , and histamine from degranulation of mast cells (Lim et al., 1986; Kerdel, 1987) . Thus, to establish the therapeutic window of these drugs, we have investigated the drug dose at which inflammatory response following PDT becomes deleterious, or fatal.
Materials and methods

Photosensitisers
The synthesis and purification of sulphonated aluminium phthalocyanine (AlPcS) and sulphonated phthalimidomethyl aluminium phthalocyanine (AlPcSP) have been described in detail previously Paquette et al., 1991a propane-1,2-diol, and saline (10:3:87) 6-9 days postinoculation when tumours had reached a diameter of 3-5 mm. After 24 h the tumour was irradiated with 650-700 nm light (400 J cm-2 at a fluence rate of 180 mW cm-2) delivered by a 1000 W Xenon lamp fitted with 10 cm water filter, and LS-700 (Corion) and 2-58 (Corning) filters. In the case of P-II a band of 600-650 nm was used at the same fluence, and fluence rate, using LS-600 (Corion) and 650-FL07-50 (Ealing) filters. Light was focused on the tumour with lenses to give a final beam 8 mm in diameter. Tumour temperature was measured (Brasseur et al., 1987b) and rose to 35°C (externally) and 32°C (internally) after 10 min, in both cases the temperature remained constant for the remainder of the irradiation time. Tumour response was assessed qualitatively and followed from initial necrosis (within 48 h), to cure (within 15-30 days). Cure was defined as complete eradication of tumour mass and regrowth of non-neoplastic tissue in its place. Nine mice were used to confirm the minimal dose of dye needed to reach the cure.
Results
The potential of photosensitisers to affect tumours upon PDT via a direct cell killing mechanisms can be deduced using an in vivo/in vitro cell survival assay (Henderson, 1990 In vivo/in vitro assay BALB/c mice were implanted with two EMT-6 tumours in the hind thighs. When the tumours reached a diameter of 3-5 mm (6-9 days) mice were injected with 10 gsmol kg-' of Pc or 10 mg kg-' of P-II in saline containing 10% Cremophor EL and 3% propane-1,2-diol. 24 h post-injection of drug animals were sacrificed and the tumours were excised, minced, and enzymatically digested for 30 min in 10 ml Hank's buffer saline solution, containing 10 mM CaC12, 6.5 U proteinase K (Sigma), 3 U nuclease micrococcal (Sigma) and 17 U collagenase (Sigma). The digested preparation was then filtered through a 200 mesh sieve and centrifuged at 600 g for 5 min. Two hundred cells were placed in 60 mm Petri dishes and incubated for 3 h at 37°C in 5% CO2 in Waymouths' culture medium to allow adhesion to the support. Cells were illuminated with red light from two 500 W tungsten/halogen lamps (Sylvania) fitted with a circulating, refrigerated filter containing aqueous Rhodamine (OD580 = 1.25), and a red filter (Kodak, no. 23A). Cells were illuminated with a fluence from 1 to 40 J cm-2calculated for a window of 40 nm centred on the maximum absorption wavelength of each dye.
Therapeutic window
Tumour bearing animals were prepared and irradiated in a procedure identical to that used for photodynamic therapy (see above); however, in this experiment drug doses were increased sequentially, until the lethal dose for PDT with that compound was found. Any sub-lethal deleterious effects were also assessed qualitatively. doses. AlPcS4 and P-II attained the same tumour response only at concentrations about 10 and 20 times higher, in mgkg-' unit, respectively. Tumour response results for all compounds tested are summarised in Table I. The therapeutic window of these dyes was determined by increasing progressively the injected dose. Results in Table II indicate that AlPcS2 and AlPcS3.2P0.4 can be used safely in this model under our experimental conditions, up to a limit of 1 tmol kg-'. Above this dose, deleterious effect ranging from inflammation to complete necrosis of the leg and death result. Thus, these two dyes showed a poor therapeutic window as EMT-6 tumour could not be cured at a dose lower than 0.5 jmol kg-1. On the other hand, increasing the number of phthalimidomethyl groups, as in fraction AlPcS24PI.4, increased the therapeutic window by a factor of four as compared to AlPcS2.
Discussion
The use of Photofrin II'm in PDT protocols induces necrosis mainly by tumour microcirculation stasis (Fingar & Henderson, 1987; Selman et al., 1985; Reed et al., 1989) . The resulting indirect cell killing is usually incomplete allowing tumour regrowth unless blood vessels surrounding the tumour are also destroyed (Star et al., 1986) . In the clinic this limits efficient treatment not only of single, well-defined tumours where red light could be easily focused, but also when more diffuse illumination must be used, as in the case of multiple tumours in bladder cancer (Jocham et al.,1989) . Furthermore, severe damage to normal tissue could arise and this deleterious effect greatly compromises successful cure of malignant tumour. Accordingly there is a need for a new PDT photosensitiser acting more directly on neoplasmic cells and sulphonated phthalocyanines have shown promise in this regard.
Apart from distribution and PDT effect in normal rat colon with AlPcS purified with respect to sulfonation (Chatlani et al., 1991), most in vivo studies with sulphonated aluminium phthalocyanines reported to date were conducted with mixtures of differently sulphonated products (Barr et al., 1990; Chan et al., 1986; Tralau et al., 1987) . Resolution of sulphonated metallo phthalocyanines into homogeneous components requires tedious chromatographic procedures and mainly in vitro biological testing on these individual compounds has been reported (Brasseur et al., a 24 h after injection of photosensitiser, tumour bearing BALB/c mice were illuminated at a fluence of400 J cm-2. An initial necrosis appeared within 48 h post-treatment and was followed to cure.
1987a ; Paquette et al., 1988; Peng et al., 1991 Lier, 1991b) .
Using the in vivo/in vitro cell survival assay as described in this report, actual in vivo distribution and cell uptake of dye are respected, while an in vitro illumination allows accurate quantification of direct cell killing potential. EMT-6 cell survival curves (Figure 2 ) after in vivo administration of 10 mg kg-' P-II revealed that at the maximum fluence of 40 J cm-2 only 20% of the EMT-6 cells were inactivated. However to elicit a complete in vivo tumour response with the same dye dose, a 10-fold higher fluence of 400 J cm-2 was required, suggesting that at least at the top layer of the tumour, direct cell killing may contribute to tumour necrosis. Overall tumour cell survival after in vivo PDT with P-IT has previously been shown to be high, this suggests a predominantly indirect action mechanism (Fingar & Henderson, 1987) which is in agreement with the high cell survival observed in our in vivo/in vitro test.
Unlike P-II, all three phthalocyanines tested in this study exhibited high potential for direct cell killing in PDT. In vitro photoinactivation of EMT-6 cells after in vivo administration of 10 tcmol kg-' dye gave LD90 varying from 15.7 J cm2 for AlPcS2 through 5.2 and 6.4 J cm-2 for AlPcS2.4P,.2 and AlPcS3.2P0.4 respectively (Figure 2 ). The phthalimidomethylated ALPcSP LD90 values are approximatley half that of AlPcS2 which parallels their relative photoactivities under in vitro conditions with Chinese hamster fibroblast V-79 cells (Paquette et al., 1991a) . In additon to passive diffusion, dye uptake by neoplastic cells in vivo can be mediated by endocytosis (Ben-Hur et al., 1987; Roberts and Berns, 1989) . These processes are modulated by dye interaction with constituents in interstitial liquid such as albumin, collagene or low density lipoproteins, which compete with dye uptake by neoplastic cells. On the other hand, binding of hydrophilic dye on low density lipoprotein is believed to favour specific endocytosis by neoplastic cells (Kessel et al., 1987) . Our data suggest that addition of phthalimidomethyl groups to AlPcS favours their localisation in neoplasmic cells, resulting in a two fold increase in direct cell killing and a 4-fold increase in the therapeutic window.
Comparison of the in vivo and in vitro phototoxicities (Paquette et al., 1991a) of the AlPcS and AlPcSP suggest that the hydrophobic/amphiphilic properties of the dyes have less impact on the in vivo as compared to the in vitro activities. In the V-79 cell survival assay, the more hydrophobic and amphiphilic AlPcS2.4PI.4 fraction was over 3-fold more photoactive than the hydrophylic AlPCS3.2Po.4 fraction. In the in vivo/in vitro EMT-6 cell survival assay, both dye preparations exhibited similar direct cell killing potentials. This suggests the futility of further attempts to increase the hydrophobic/amphiphilic character of these photosensitisers in order to improve their direct cell killing potential during in vivo PDT.
The degree of sulfonation of AlPcS strongly effects the a Experiments with Photofrin II gave a lethal dose of 20mg kg-'. b 24 h after injection of photosensitiser, tumour bearing BALB/c mice were illuminated at a fluence of400 J cm2. An initial necrosis appeared within 48 h post-treatment and was followed to cure. minimal drug dose required for tumour response. Thus, AIPcS2 is ten times more photoactive than the corresponding AlPcS4 (0.5 pmol kg-' and 5 fmol kg-1, respectively), confirming that the increase in hydrophobic/amphiphilic character of AlPcS improves the effective overall distribution of the dye in the tumour. This assumption is in agreement with recent observations by Peng et al. (1990a,b) showing that AlPcS2 at 24h post-injection, mainly localises in the neoplastic cells of LOX tumour bearing mice. In contrast, the AlPcS4 remained mainly in the stroma, even at 48 h postinjection. It is likely that the highly hydrophilic character of AlPcS4 contributes to strong binding to the protein component in the stroma, while the amphiphilic nature of AlPcS2 promotes interaction with the plasma membrane of neoplastic cells. Adding lipophilic phthalimidomethyl substituents to AlPcS did not significantly improve the required dye dose for 100% tumour cure. Both AlPcS2.4P1.4 and AlPcS3.2P0.4 fractions required, in our EMT-6 model, the same minimal dye dose for tumour cure as AlPcS2 (0.5 Jmol kg-'). It thus appears that the inclusion of hydrophobic phthalimidomethyl groups in AlPcS has a beneficial PDT effect in that it outweighs the expected decrease in activity resulting from higher sulphonation levels (Brasseur et al., 1987a) .
Extrapolation of the high direct cell killing potential of the AlPcSP to the mechanisms of the PDT response of the EMT-6 tumour, should be done with caution. Although the minimal injected dye dose for tumour response was 20-fold lower than the dye dose employed in the in vivo/in vitro cell survival assay (0.5 and 10 tLmol kg-', respectively), the fluence in the in vivo PDT assay was at least 60-fold higher than that required for a 90% cell inactivation in the in vivo/in vitro assay. Furthermore, absorption of red light by the tumour tissue allows for only about 20% of incident light to reach the lower part of tumour (Henderson, 1989) . These factors combined suggest that the deeper seated part of the EMT-6 tumour will receive somewhat lower combined light/ dye doses than the LD90 values obtained in the in vivo/in vitro cell killing assay. Thus it is likely that in the deeper seated parts of the tumour, and at the lower effective dye doses, tumour cure will involve indirect mechanism for cell killing.
Indirect tumour cell killing after PDT has been related to the release of vasoactive agents including histamine and prostaglandins, and this, in addition to local effects, could trigger also substantial systemic toxicity (Fingar et al., 1991; Kerdel et al., 1987; Lim et al., 1986) . Accordingly, we evaluated the therapeutic window in our tumour model, i.e. the range of the minimal dye doses required for 100% tumour cure and the dose which induced systemic toxicity (Table II) . Under our experimental conditions both AlPcS2 and AlPcS3.2PO.4 proved highly phototoxic at 5.0 LLmol kg-' suggeting that, although these compounds have a good potential for direct cell killing, they also localise in sites responsible for the release of inflammatory agents. Among the three sensitisers which exhibit photodynamic action at 0.5 ltml kg-', the AlPcS2.4PI.2 has the largest therapeutic window. This suggests that the addition of the phthalimidomethyl group on amphiphilic AlPcS2 reduces unwanted dye interaction with cells capable of releasing vasoactive agents (e.g. mast cells).
In conclusion, these results imply a subtle balance between the hydrophobic and the amphiphilic characteristics of phthalocyanine sensitisers and their action mechanisms, with important implications in terms of both photodynamic potency and deleterious effects. The addition of the hydrophobic phthalimidomethyl groups on lower sulphonated AlPcS should improve the PDT outcome by increasing direct tumour cell killing while limiting deleterious effects on normal surrounding tissue. In the EMT-6 tumour model, the current class of phthalocyanines induces a higher direct cell killing and tumour response as compared to P-1I. Further chemical modifications should be aimed at improving the therapeutic window, which would allow the administration of higher doses of dye and red light, resulting in augmented direct cell killing and cure of malignant tumours. 
